1974
G&N Started by Graham Griffiths and Bent Nielsen as a laboratory business, manufacturing and selling petri dishes alongside other lab consumables.

1980
G&N expanded the range of laboratory consumables by becoming distributors to Sterilin.

1994
Giles Griffiths became CEO of G&N, and the company moved into the clinical waste market offering a range of Griff bins to NHS for clinical waste disposal.

2000
G&N expanded the clinical waste range to offer various other containment solutions, thus becoming the provider of the largest range in the UK.

1974
G&N Started by Graham Griffiths and Bent Nielsen as a laboratory business, manufacturing and selling petri dishes alongside other lab consumables.

1980
G&N expanded the range of laboratory consumables by becoming distributors to Sterilin.

1994
Giles Griffiths became CEO of G&N, and the company moved into the clinical waste market offering a range of Griff bins to NHS for clinical waste disposal.

2000
G&N expanded the clinical waste range to offer various other containment solutions, thus becoming the provider of the largest range in the UK.

2006
G&N started the journey of transitioning into a global medical device company. Started the development of the Anti Embolism Stocking range, exploiting a gap in the market for a new innovative product.

2009
G&N’s AES range supplied 25% of the UK market. We expanded our DVT prevention portfolio with PneumaPress an intermittent pneumatic compression device, gaining a respectable market share within an acute hospital setting.

2015
After 6 more years of supplying to the NHS and continuous product innovation, the birth of FITLEGS, G&N’s compression hosiery brand became market leaders, obtaining 60% of the UK Anti-Embolism stocking market.

2016
G&N expanded the FITLEGS product range. Developing FITLEGS Everyday & Life, for those that seek everyday compression to reduce aches and pains in the legs and feet; FITLEGS Sport for those looking to improve endurance and recovery.

2017
G&N introduced the Geko device to the market, this revolutionary innovation provides electro stimulation to the perineal nerve to improve blood flow. This addition completed G&N’s DVT prophylaxis portfolio, providing a complete offering of solutions in an acute hospital setting.

2018
G&N expanded the product portfolio acquiring the Proctolux and Sigmolux scopes range; along with the introduction of Vanish Point a range of retractable needles. At the same time G&N moved the waste containment business into a Laboratory division to better serve our customers and develop technologies and products that are required for a more sustainable future.

2019
Expanded our FITLEGS compression hosiery range, bringing out FITLEGS 2 our class 2 medical range for those that clinically require higher strength compression therapy.

2020
G&N Launched our online retail store www.fitlegs.com, providing compression to the community and healthcare professionals for their day to day use. Conducting campaigns providing free socks to NHS staff throughout the pandemic to support those on the front line. Our FITLEGS 2 product was listed for prescription on the NHS FP10 Drug Tariff.

G&N Vanishpoint Product Information - Brochure